Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

Background: Lung cancer is the leading cause of cancer-related death in the United States.
Because early-stage lung cancer is associated with lower mortality than late-stage disease …

Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …

Background Diagnosis of lung cancer frequently occurs in its later stages. Low-dose
computed tomography (LDCT) could detect lung cancer early. Objectives To estimate the …

Abstract Background The Nelson mortality results were presented in September 2018. Four
other randomized control trials (RCTs) were also reported the latest mortality outcomes in …

Context Lung cancer is the leading cause of cancer death. Most patients are diagnosed with
advanced disease, resulting in a very low 5-year survival. Screening may reduce the risk of …

Background Lung cancer is the largest contributor to mortality from cancer. The National
Lung Screening Trial (NLST) showed that screening with low-dose helical computed …

Importance Low-dose computed tomography (CT) screening was shown to reduce lung
cancer–specific mortality in a large randomized trial of a high-risk population. The decision …

Objectives Lung cancer is the leading cause of death among all cancers. An estimated 29%
of the global population older than 15 years currently smokes tobacco. The presence of a …

Background Randomized controlled trials have evaluated the efficacy of low-dose CT
(LDCT) lung cancer screening on lung cancer (LC) outcomes. Objective Meta-analyze LDCT …